[PLX] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
06-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -174.27%
YoY- 22.72%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 17,759 14,248 12,247 10,439 27,018 663 2,006 326.25%
PBT 291 -3,560 -7,743 -7,264 9,781 -15,544 -11,294 -
Tax 180 34 3 190 99 230 75 78.97%
NP 291 -3,560 -7,743 -7,264 9,781 -15,544 -11,294 -
Tax Rate -61.86% - - - -1.01% - - -
Total Cost 17,468 17,808 19,990 17,703 17,237 16,207 13,300 19.87%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 1.64 -24.99 -63.22 -69.59 36.20 -2,344.49 -563.01 -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS 0.02 -0.24 -0.52 -0.49 0.66 -1.05 -0.77 -
EPS Diluted 0.02 -0.24 -0.52 -0.49 0.66 -1.05 -0.77 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.